Effect of growth hormone (GH) therapy on obstructive sleep apnea (OSA) in children with Prader Willi Syndrome (PWS) Source: Eur Respir J 2005; 26: Suppl. 49, 614s Year: 2005
Respiration and sleep in young individuals with Prader-Willi syndrome treated with growth hormone Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005
The effect of growth hormone therapy, adenotonsillectomy and genotype on obstructive sleep apnea in children with Prader-Willi syndrome Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children Year: 2013
Sleep disordered breathing in Prader Willi syndrome post recombinant human growth hormone therapy Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011
Sleep apnoea and quality of life in growth hormone deficient adults before and six months following growth hormone therapy Source: Eur Respir J 2005; 26: Suppl. 49, 570s Year: 2005
Central and obstructive apnoea-hypopnea indices pre and post growth hormone commencement in children with Prader-Willi syndrome following introduction of a screening programme Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020
The growth hormone receptor +561G allele is associated with obesity and the obstructive sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Role of growth hormone-releasing hormone in sleep and growth impairments induced by upper airway obstruction in rats Source: Eur Respir J 2011; 38: 870-877 Year: 2011
Serum and mucosal brain derived neurotrophic factor (BDNF) in severe obstructive sleep apnea syndrome (OSAS). Effects of CPAP treatment on BDNF serum levels. Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019
Sleep characteristics of children with Prader-Willi syndrome Source: Annual Congress 2009 - Sleep apnoea across the ages Year: 2009
The effect of BPAP therapy on basal metabolism rate in patients with obesity hypoventilation syndrome Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015
Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Correlation between OSA score and cardiorespiratory parameters during sleep in children and young adults with Prader-Willi syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 87s Year: 2001
Effects of TH9507, a growth hormone releasing factor (GRF) analog, on functional performance in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004
Sleep disordered breathing (SDB) in patients with Beckwith-Wiedemann syndrome (BWS) Source: International Congress 2016 – Latest advances in paediatric sleep medicine Year: 2016
Frequency of metabolic syndrome (MS) in patients with obstructive sleep apnoea (OSA) depends on adopted definition Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Long term effects of CPAP therapy in sleep apnea patients with metabolic syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Metabolic and constitutional changes in COPD patients and their relations to their sleep pattern Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Ectopic adrenocorticotropic hormone syndrome: clinical features, diagnosis, treatment and long-term observation. Impact of bronchial carcinoid tumors. Source: International Congress 2018 – Pleural effusions, infections and tumours Year: 2018
Sleep apnea syndrome and periodic leg movements (PLMs) in sleep. Screening of 122 patients Source: Eur Respir J 2007; 30: Suppl. 51, 592s Year: 2007